Nedaplatin: a cisplatin derivative in cancer chemotherapy

Nedaplatin, a cisplatin analog, has been developed to decrease the toxicities induced by cisplatin, such as nephrotoxicity and gastrointestinal toxicity. The dose of nedaplatin is determined by body surface area, not by the area under the curve (AUC). The recommended therapeutic dose is 80–100 mg/m(...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimada, Muneaki, Itamochi, Hiroaki, Kigawa, Junzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658440/
https://www.ncbi.nlm.nih.gov/pubmed/23696716
http://dx.doi.org/10.2147/CMAR.S35785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658440/
https://www.ncbi.nlm.nih.gov/pubmed/23696716
http://dx.doi.org/10.2147/CMAR.S35785

Ejemplares similares